Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Raloxifene Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 877Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EU and South Korean research organisations sign an agreement to work together
    EU and South Korean research organisations sign an agreement to work together

    18 Nov 2020

    // EUROPA

    https://ec.europa.eu/digital-single-market/en/news/eu-and-south-korean-research-organisations-sign-agreement-work-together-development-covid-19

    EUROPA
    18 Nov 2020
    Share Share
    Italy okays trial of osteoporosis drug to treat COVID-19
    Italy okays trial of osteoporosis drug to treat COVID-19

    28 Oct 2020

    // Emilio Parodi REUTERS

    https://www.reuters.com/article/us-health-coronavirus-italy-drug/italy-okays-trial-of-osteoporosis-drug-to-treat-covid-19-idUSKBN27C136

    Emilio Parodi REUTERS
    28 Oct 2020
    Share Share
    Italy gives approval to trial osteoporosis drug for Covid-19 treatment
    Italy gives approval to trial osteoporosis drug for Covid-19 treatment

    28 Oct 2020

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/italy-osteoporosis-drug-covid/

    PHARMACEUTICAL-TECHNOLOGY
    28 Oct 2020
    Share Share
    Italian Medicines Agency (AIFA) authorizes Raloxifene Clinical Trial
    Italian Medicines Agency (AIFA) authorizes Raloxifene Clinical Trial

    27 Oct 2020

    // FIRSTWORLDPHARMA

    https://www.firstwordpharma.com/node/1768574?tsid=28®ion_id=4

    FIRSTWORLDPHARMA
    27 Oct 2020
    Share Share
    Italy gives approval to trial osteoporosis drug for Covid-19 treatment
    Italy gives approval to trial osteoporosis drug for Covid-19 treatment

    27 Oct 2020

    // PHARMACEUTICALS-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/italy-osteoporosis-drug-covid/

    PHARMACEUTICALS-TECHNOLOGY
    27 Oct 2020
    Share Share
    Cadila Pharms Generic Raloxifene Hydrochloride Receives Approval in US
    Cadila Pharms Generic Raloxifene Hydrochloride Receives Approval in US

    22 Aug 2020

    // FDA FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211324

    FDA FDA
    22 Aug 2020
    Share Share